Skip to main content

Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 30% on print and eBooks.

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

  • 1st Edition - June 27, 2013
  • Editors: Lisa Plitnick, Danuta Herzyk
  • Language: English
  • Hardback ISBN:
    9 7 8 - 0 - 1 2 - 3 9 4 8 1 0 - 6
  • eBook ISBN:
    9 7 8 - 0 - 1 2 - 3 9 4 8 2 3 - 6

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharma… Read more

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.